ONL Therapeutics

ONL Therapeutics, Inc. was founded in 2011 and is headquartered in Ann Arbor, Michigan, USA. It is a biotechnology and pharmaceutical company. The company primarily focuses on developing new therapies for retinal diseases to protect and improve patients' vision. Currently, ONL is researching a series of drugs for the treatment of blinding conditions such as retinal detachment, glaucoma, and age-related macular degeneration (AMD).